Form 4 for BBNX Beta Bionics, Inc.
Accepted 2025-12-02 00:00:00 ET · period of report 2025-12-01 · accession 0001810701-25-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-12-02 | 2025-12-01 | BBNX | Palasis Maria | Dir | S - Sale | $29.55 | -1,406 | 8,435 | -14% | -$41.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-01 | S | D | 906 | $29.33 | 8,935 | D | — | — | (F2) The weighted average sale price for the transaction reported was $29.3269 and the range of prices were between $28.75 and $29.63. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 2 | Common | Common Stock | 2025-12-01 | S | D | 500 | $29.96 | 8,435 | D | — | — | (F3) The weighted average sale price for the transaction reported was $29.9640 and the range of prices were between $29.80 and $30.23. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |